Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Jennifer E. Miller"'
Autor:
Maryam Mooghali, Austin M. Stroud, Dong Whi Yoo, Barbara A. Barry, Alyssa A. Grimshaw, Joseph S. Ross, Xuan Zhu, Jennifer E. Miller
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Artificial intelligence (AI) is increasingly used for prevention, diagnosis, monitoring, and treatment of cardiovascular diseases. Despite the potential for AI to improve care, ethical concerns and mistrust in AI-enabled healthcar
Externí odkaz:
https://doaj.org/article/afb3b05e8e8a4264a514fb8f25b94967
Autor:
Xuan Zhu, PhD, Austin M. Stroud, MA, Sarah A. Minteer, PhD, Dong Whi Yoo, PhD, Jennifer L. Ridgeway, PhD, Maryam Mooghali, MD, MSc, Jennifer E. Miller, PhD, Barbara A. Barry, PhD
Publikováno v:
Mayo Clinic Proceedings: Digital Health, Vol 2, Iss 3, Pp 492-493 (2024)
Externí odkaz:
https://doaj.org/article/6990f921e2c84348965b6bcef41922bb
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-17 (2022)
Abstract Background Repurposing is a drug development strategy receiving heightened attention after the Food and Drug Administration granted emergency use authorization of several repurposed drugs to treat Covid-19. There remain knowledge gaps on the
Externí odkaz:
https://doaj.org/article/fff486a42e014360b75292bb6d546f55
Autor:
Joshua D. Wallach, Anita T. Luxkaranayagam, Sanket S. Dhruva, Jennifer E. Miller, Joseph S. Ross
Publikováno v:
BMC Medicine, Vol 17, Iss 1, Pp 1-10 (2019)
Abstract Background Postmarketing commitments are clinical studies that pharmaceutical companies agree to conduct at the time of FDA approval, but which are not required by statute or regulation. As FDA increasingly adopts a lifecycle evaluation proc
Externí odkaz:
https://doaj.org/article/ff4fd1e9198f4a8b969474f886ee7fd3
Autor:
Constance X. Zou, Jessica E. Becker, Adam T. Phillips, James M. Garritano, Harlan M. Krumholz, Jennifer E. Miller, Joseph S. Ross
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-11 (2018)
Abstract Background Mandatory trial registration, and later results reporting, were proposed to mitigate selective clinical trial publication and outcome reporting. The Food and Drug Administration (FDA) Amendments Act (FDAAA) was enacted by Congress
Externí odkaz:
https://doaj.org/article/064d436aeeb448f7ae49a0e39fe55e30
Autor:
Anand D. Gopal, Joshua D. Wallach, Jenerius A. Aminawung, Gregg Gonsalves, Rafael Dal-Ré, Jennifer E. Miller, Joseph S. Ross
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-13 (2018)
Abstract Background Registration of clinical trials is critical for promoting transparency and integrity in medical research; however, trials must be registered in a prospective fashion to deter unaccounted protocol modifications or selection of alte
Externí odkaz:
https://doaj.org/article/69e4cdb2b10943b5be1833b9b93cd751
Publikováno v:
BMC Research Notes, Vol 10, Iss 1, Pp 1-4 (2017)
Abstract Objective We sought to determine the characteristics of “expanded access” and “compassionate use” programs registered in ClinicalTrials.gov and to determine the percentage of drugs provided through these programs that ultimately rece
Externí odkaz:
https://doaj.org/article/60be14d466b34ee5ac1f749d9428145d
Autor:
Adam T. Phillips, Nihar R. Desai, Harlan M. Krumholz, Constance X. Zou, Jennifer E. Miller, Joseph S. Ross
Publikováno v:
Trials, Vol 18, Iss 1, Pp 1-10 (2017)
Abstract Background Selective clinical trial publication and outcome reporting has the potential to bias the medical literature. The 2007 Food and Drug Administration (FDA) Amendment Act (FDAAA) mandated clinical trial registration and outcome report
Externí odkaz:
https://doaj.org/article/d80dfa8fa79947329ec1f5ed26dbc0da
Autor:
Jennifer E. Miller, Stephen Latham
Publikováno v:
The American Journal of Bioethics. 23:89-91
Publikováno v:
JAMA Oncology.
This Editorial discusses the existing policy efforts in the US for ensuring adequate racial and ethnic diversity in clinical trials, identifies barriers to consistency and acceptable representation, and suggests measures to address them.